Role for the Clock gene in bipolar disorder

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 72, Issue , 2007, Pages 637-644

  McClung, C A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; PROTEIN BMAL1; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR CLOCK; MOOD STABILIZER; TRANSCRIPTION FACTOR ARNTL;

AFFECT; ANIMAL; BIPOLAR DISORDER; BRAIN; CIRCADIAN RHYTHM; GENETICS; HUMAN; MOUSE; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; SUPRACHIASMATIC NUCLEUS; BRAIN REGION; GENE FUNCTION; GENETIC ASSOCIATION; MOOD; MOOD DISORDER; NONHUMAN;

AFFECT; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIPOLAR DISORDER; BRAIN; CIRCADIAN RHYTHM; HUMANS; MICE; MUTATION; SUPRACHIASMATIC NUCLEUS; TRANS-ACTIVATORS;

EID: 48249090376     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2007.72.031     Document Type: Conference Paper

References (111)

1. Akhisaroglu M., Kurtuncu M., Manev H., and Uz T. 2005. Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice. Pharmacol. Biochem. Behav. 80: 371.
2. Aston-Jones G., Chen S., Zhu Y., and Oshinsky M.L. 2001. A neural circuit for circadian regulation of arousal. Nat. Neurosci. 4: 732.
3. Atkinson M., Kripke D.F., and Wolf S.R. 1975. Autorhythmometry in manic-depressives. Chronobiologia 2: 325.
4. Banasr M., Soumier A., Hery M., Mocaer E., and Daszuta A. 2006. Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biol. Psychiatry 59 : 1087.
5. Barassin S., Raison S., Saboureau M., Bienvenu C., Maitre M., Malan A., and Pevet P. 2002. Circadian tryptophan hydroxylase levels and serotonin release in the suprachiasmatic nucleus of the rat. Eur. J. Neurosci. 15: 833.
6. Benedetti F., Serretti A., Colombo C., Barbini B., Lorenzi C., Campori E., and Smeraldi E. 2003. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 123: 23.
7. Berchtold N.C., Oliff H.S., Isackson P., and Cotman C.W. 1999. Hippocampal BDNFmRNAshows a diurnal regulation, primarily in the exon III transcript. Brain Res. Mol. Brain Res. 71: 11.
8. Bersudsky Y., Shaldubina A., and Belmaker R.H. 2007. Lithium's effect in forced-swim test is blood level dependent but not dependent on weight loss. Behav. Pharmacol. 18: 77.
9. Boivin D.B. 2000. Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders. J Psychiatry Neurosci. 25: 446.
10. Booker J.M., Hellekson C.J., Putilov A.A., and Danilenko K.V. 1991. Seasonal depression and sleep disturbances in Alaska and Siberia: A pilot study. Arctic Med. Res. Suppl.: 281.
11. Bunney W.E. and Bunney B.G. 2000. Molecular clock genes in man and lower animals: Possible implications for circadian abnormalities in depression. Neuropsychopharmacology 22: 335.
12. Calil H.M., Zwicker A.P., and Klepacz S. 1990. The effects of lithium carbonate on healthy volunteers: Mood stabilization? Biol. Psychiatry 27: 711.
13. Campbell S.S., Gillin J.C., Kripke D.F., Janowsky D.S., and Risch S.C. 1989. Lithium delays circadian phase of temperature and REM sleep in a bipolar depressive: A case report. Psychiatry Res. 27: 23.
14. Castaneda T.R., de Prado B.M., Prieto D., and Mora F. 2004. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: Modulation by light. J. Pineal Res. 36: 177.
15. Chelminski I., Ferraro F.R., Petros T.V., and Plaud J.J. 1999. An analysis of the "eveningness-morningness" dimension in "depressive" college students. J. Affect. Disord. 52: 19.
16. Coon S.L., McCune S.K., Sugden D., and Klein D.C. 1997. Regulation of pineal alpha1B-adrenergic receptor mRNA: Day/night rhythm and beta-adrenergic receptor/cyclic AMP control. Mol. Pharmacol. 51: 551.
17. Dehpour A.R., Sadr S.S., Azizi M.R., Namiranian K., Farahani M., and Javidan A.N. 2002. Lithium inhibits the development of physical dependence to clonidine in mice. Pharmacol. Toxicol. 90: 89.
18. den Boer J.A., Bosker F.J., and Meesters Y. 2006. Clinical efficacy of agomelatine in depression: The evidence. Int. Clin. Psychopharmacol. (suppl. 1) 21: S21.
19. Deurveilher S. and Semba K. 2005. Indirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: Implications for the circadian control of behavioural state. Neuroscience 130: 165.
20. Dokucu M.E., Yu L., and Taghert P.H. 2005. Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila. Neuropsychopharmacology 30: 2216.
21. Dolci C., Montaruli A., Roveda E., Barajon I., Vizzotto L., Grassi Zucconi G., and Carandente F. 2003. Circadian variations in expression of the trkB receptor in adult rat hippocampus. Brain Res. 994: 67.
22. Dranovsky A. and Hen R. 2006. Hippocampal neurogenesis: Regulation by stress and antidepressants. Biol. Psychiatry 59: 1136.
23. Drennan M.D., Klauber M.R., Kripke D.F., and Goyette L.M. 1991. The effects of depression and age on the Horne-Ostberg morningness-eveningness score. J. Affect. Disord. 23: 93.
24. Dudley T.E., Dinardo L.A., and Glass J.D. 1999. In vivo assessment of the midbrain raphe nuclear regulation of serotonin release in the hamster suprachiasmatic nucleus. J. Neurophysiol. 81: 1469.
25. Easton A., Arbuzova J., and Turek F.W. 2003. The circadian Clock mutation increases exploratory activity and escapeseeking behavior. Genes Brain Behav. 2: 11.
26. Ehlen J.C., Grossman G.H., and Glass J.D. 2001. In vivo resetting of the hamster circadian clock by 5-HT7 receptors in the suprachiasmatic nucleus. J. Neurosci. 21: 5351.
27. Engeland W.C. and Arnhold M.M. 2005. Neural circuitry in the regulation of adrenal corticosterone rhythmicity. Endocrine 28: 325.
28. Estroff T.W., Dackis C.A., Gold M.S., and Pottash A.L. 1985. Drug abuse and bipolar disorders. Int. J. Psychiatry Med. 15: 37.
29. Frank E., Swartz H.A., and Kupfer D.J. 2000. Interpersonal and social rhythm therapy: Managing the chaos of bipolar disorder. Biol. Psychiatry 48: 593.
30. Fulton S., Pissios P., Manchon R.P., Stiles L., Frank L., Pothos E.N., Maratos-Flier E., and Flier J.S. 2006. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51: 811.
31. Gelenberg A.J., Kane J.M., Keller M.B., Lavori P., Rosenbaum J.F., Cole K., and Lavelle J. 1989. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N. Engl. J. Med. 321: 1489.
32. Giedke H. and Schwarzler F. 2002. Therapeutic use of sleep deprivation in depression. Sleep Med. Rev. 6: 361.
33. Gould T.D. and Manji H.K. 2005. Glycogen synthase kinase-3: A putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30: 1223.
34. Grandin L.D., Alloy L.B., and Abramson L.Y. 2006. The social zeitgeber theory, circadian rhythms, and mood disorders: Review and evaluation. Clin. Psychol. Rev. 26: 679.
35. Hafen T. and Wollnik F. 1994. Effect of lithium carbonate on activity level and circadian period in different strains of rats. Pharmacol. Biochem. Behav. 49: 975.
36. Hamet P. and Tremblay J. 2006. Genetics of the sleep-wake cycle and its disorders. Metabolism 55: S7.
37. Hamon M. and Bourgoin S. 2006. Pharmacological profile of antidepressants: A likely basis for their efficacy and side effects? Eur. Neuropsychopharmacol. (suppl. 5) 16: S625.
38. Hanoun N., Mocaer E., Boyer P.A., Hamon M., and Lanfumey L. 2004. Differential effects of the novel antidepressant agomelatine (S 20098) versus fluoxetine on 5-HT1A receptors in the rat brain. Neuropharmacology 47: 515.
39. Harms E., Young M.W., and Saez L. 2003. CK1 and GSK3 in the Drosophila and mammalian circadian clock. Novartis Found. Symp. 253: 267.
40. Harris G.C. and Aston-Jones G. 2006. Arousal and reward: A dichotomy in orexin function. Trends Neurosci. 29: 571.
41. Hirsch-Rodriguez E., Imbesi M., Manev R., Uz T., and Manev H. 2007. The pattern of melatonin receptor expression in the brain may influence antidepressant treatment. Med. Hypotheses 69: 120.
42. Hommel J.D., Trinko R., Sears R.M., Georgescu D., Liu Z.W., Gao X.B., Thurmon J.J., Marinelli M., and DiLeone R.J. 2006. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 51: 801.
43. Iijima M., Nikaido T., Akiyama M., Moriya T., and Shibata S. 2002. Methamphetamine-induced, suprachiasmatic nucleusindependent circadian rhythms of activity and mPer gene expression in the striatum of the mouse. Eur. J. Neurosci. 16: 921.
44. Iitaka C., Miyazaki K., Akaike T., and Ishida N. 2005. A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J. Biol. Chem. 280: 29397.
45. Johansson C., Willeit M., Smedh C., Ekholm J., Paunio T., Kieseppa T., Lichtermann D., Praschak-Rieder N., Neumeister A., Nilsson L.G., Kasper S., Peltonen L., Adolfsson R., Schalling M., and Partonen T. 2003. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 28: 734.
46. Johnsson A., Engelmann W., Pflug B., and Klemke W. 1983. Period lengthening of human circadian rhythms by lithium carbonate, a prophylactic for depressive disorders. Int. J. Chronobiol. 8: 129.
47. Kafka M.S., Wirz-Justice A., Naber D., Moore R.Y., and Benedito M.A. 1983. Circadian rhythms in rat brain neurotransmitter receptors. Fed. Proc. 42: 2796.
48. Kessler R.C., Nelson C.B., McGonagle K.A., Edlund M.J., Frank R.G., and Leaf P.J. 1996. The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. Am. J. Orthopsychiatry 66: 17.
49. Khaldy H., Leon J., Escames G., Bikjdaouene L., Garcia J.J., and Acuna-Castroviejo D. 2002. Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: Effects of pinealectomy and of melatonin treatment. Neuroendocrinology 75: 201.
50. King D.P., Zhao Y., Sangoram A.M., Wilsbacher L.D., Tanaka M., Antoch M.P., Steeves T.D., Vitaterna M.H., Kornhauser J.M., Lowrey P.L., Turek F.W., and Takahashi J.S. 1997. Positional cloning of the mouse circadian clock gene. Cell 89: 641.
51. Klemfuss H. 1992. Rhythms and the pharmacology of lithium. Pharmacol. Ther. 56: 53.
52. Kochman L.J., Weber E.T., Fornal C.A., and Jacobs B.L. 2006. Circadian variation in mouse hippocampal cell proliferation. Neurosci. Lett. 406: 256.
53. Kripke D.F., Mullaney D.J., Atkinson M., and Wolf S. 1978. Circadian rhythm disorders in manic-depressives. Biol. Psychiatry 13: 335.
54. Kuipers S.D. and Bramham C.R. 2006. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: New insights and implications for therapy. Curr. Opin. Drug Discov. Dev. 9: 580.
55. Kurabayashi N., Hirota T., Harada Y., Sakai M., and Fukada Y. 2006. Phosphorylation of mCRY2 at Ser557 in the hypothalamic suprachiasmatic nucleus of the mouse. Chronobiol. Int. 23: 129.
56. Lam R.W. and Levitan R.D. 2000. Pathophysiology of seasonal affective disorder: A review. J. Psychiatry Neurosci. 25: 469.
57. Lenox R.H., Gould T.D., and Manji H.K. 2002. Endophenotypes in bipolar disorder. Am. J. Med. Genet. 114: 391.
58. Leproult R., Van Onderbergen A., L'Hermite-Baleriaux M., Van Cauter E., and Copinschi G. 2005. Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. Clin. Endocrinol. 63: 298.
59. LeSauter J. and Silver R. 1993. Lithium lengthens the period of circadian rhythms in lesioned hamsters bearing SCN grafts. Biol. Psychiatry 34: 75.
60. Lewy A.J., Lefler B.J., Emens J.S., and Bauer V.K. 2006. The circadian basis of winter depression. Proc. Natl. Acad. Sci. 103: 7414.
61. Liang F.Q., Walline R., and Earnest D.J. 1998. Circadian rhythm of brain-derived neurotrophic factor in the rat suprachiasmatic nucleus. Neurosci. Lett. 242: 89.
62. Magnusson A. and Boivin D. 2003. Seasonal affective disorder: An overview. Chronobiol. Int. 20: 189.
63. Malek Z.S., Dardente H., Pevet P., and Raison S. 2005. Tissuespecific expression of tryptophan hydroxylase mRNAs in the rat midbrain: Anatomical evidence and daily profiles. Eur. J. Neurosci. 22: 895.
64. Mansour H.A., Monk T.H., and Nimgaonkar V.L. 2005. Circadian genes and bipolar disorder. Ann. Med. 37: 196.
65. Mansour H.A., Wood J., Logue T., Chowdari K.V., Dayal M., Kupfer D.J., Monk T.H., Devlin B., and Nimgaonkar V.L. 2006. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav. 5: 150.
66. Maremmani I., Perugi G., Pacini M., and Akiskal H. S. 2006. Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm. J. Affect. Disord. 93: 1.
67. McClung C.A. 2007. Circadian genes, rhythms and the biology of mood disorders. Pharmacol. Ther. 114: 222.
68. McClung C.A., Sidiropoulou K., Vitaterna M., Takahashi J.S., White F.J., Cooper D.C., and Nestler E.J. 2005. Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc. Natl. Acad. Sci. 102: 9377.
69. Millan M.J., Brocco M., Gobert A., and Dekeyne A. 2005. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: Role of 5-HT2C receptor blockade. Psychopharmacology 177: 448.
70. Millan M.J., Gobert A., Lejeune F., Dekeyne A., Newman-Tancredi A., Pasteau V., Rivet J.M., and Cussac D. 2003. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J. Pharmacol. Exp. Ther. 306: 954.
71. Miller B.H., McDearmon E.L., Panda S., Hayes K.R., Zhang J., Andrews J.L., Antoch M.P., Walker J.R., Esser K.A., Hogenesch J.B., and Takahashi J. S. 2007. Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc. Natl. Acad. Sci. 104: 3342.
72. Mitterauer B. 2000. Clock genes, feedback loops and their possible role in the etiology of bipolar disorders: An integrative model. Med. Hypotheses 55: 155.
73. Narita M., Nagumo Y., Hashimoto S., Khotib J., Miyatake M., Sakurai T., Yanagisawa M., Nakamachi T., Shioda S., and Suzuki T. 2006. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci. 26: 398.
74. Naylor E., Bergmann B.M., Krauski K., Zee P.C., Takahashi J.S., Vitaterna M.H., and Turek F.W. 2000. The circadian clock mutation alters sleep homeostasis in the mouse. J. Neurosci. 20: 8138.
75. Newcomer J.W. 2006. Medical risk in patients with bipolar disorder and schizophrenia. J. Clin. Psychiatry 67: e16.
76. Nievergelt C.M., Kripke D.F., Barrett T.B., Burg E., Remick R.A., Sadovnick A.D., McElroy S.L., Keck P.E., Jr., Schork N.J., and Kelsoe J.R. 2006. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141: 234.
77. Ogden C.A., Rich M.E., Schork N.J., Paulus M.P., Geyer M.A., Lohr J.B., Kuczenski R., and Niculescu A.B. 2004. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: An expanded convergent functional genomics approach. Mol. Psychiatry 9: 1007.
78. Padiath Q.S., Paranjpe D., Jain S., and Sharma V.K. 2004. Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks. Chronobiol. Int. 21: 43.
79. Partonen T., Treutlein J., Alpman A., Frank J., Johansson C., Depner M., Aron L., Rietschel M., Wellek S., Soronen P., Paunio T., Koch A., Chen P., Lathrop M., Adolfsson R., Persson M.L., Kasper S., Schalling M., Peltonen L., and Schumann G. 2007. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann. Med. 39: 229.
80. Prickaerts J., Moechars D., Cryns K., Lenaerts I., van Craenendonck H., Goris I., Daneels G., Bouwknecht J.A., and Steckler T. 2006. Transgenic mice overexpressing glycogen synthase kinase 3beta: A putative model of hyperactivity and mania. J. Neurosci. 26: 9022.
81. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., and Goodwin F.K. 1990. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. J. Am. Med. Assoc. 264: 2511.
82. Roybal K., Theobold D., Graham A., Dinieri J.A., Russo S.J., Krishnan V., Chakravarty S., Peevey J., Oehrlein N., Birnbaum S., Vitaterna M.H., Orsulak P., Takahashi J.S., Nestler E.J., Carlezon W.A., Jr., and McClung C.A. 2007. Mania-like behavior induced by disruption of CLOCK (from the cover). Proc. Natl. Acad. Sci. 104: 6406.
83. Rusting C.L. and Larsen R.J. 1998. Diurnal patterns of unpleasant mood: Associations with neuroticism, depression, and anxiety. J. Pers. 66: 85.
84. Schaaf M.J., Duurland R., de Kloet E.R., and Vreugdenhil E. 2000. Circadian variation in BDNF mRNA expression in the rat hippocampus. Brain Res. Mol. Brain Res. 75: 342.
85. Serretti A., Artioli P., and De Ronchi D. 2004. The 5-HT2C receptor as a target for mood disorders. Expert Opin. Ther. Targets 8: 15.
86. Serretti A., Benedetti F., Mandelli L., Lorenzi C., Pirovano A., Colombo C., and Smeraldi E. 2003. Genetic dissection of psychopathological symptoms: Insomnia in mood disorders and CLOCK gene polymorphism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 121: 35.
87. Serretti A., Cusin C., Benedetti F., Mandelli L., Pirovano A., Zanardi R., Colombo C., and Smeraldi E. 2005. Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 137: 36.
88. Shastry B.S. 1997. On the functions of lithium: The mood stabilizer. Bioessays 19: 199.
89. Shieh K.R., Chu Y.S., and Pan J.T. 1997. Circadian change of dopaminergic neuron activity: Effects of constant light and melatonin. Neuroreport 8: 2283.
90. Shirayama M., Shirayama Y., Iida H., Kato M., Kajimura N., Watanabe T., Sekimoto M., Shirakawa S., Okawa M., and Takahashi K. 2003. The psychological aspects of patients with delayed sleep phase syndrome (DSPS). Sleep Med. 4: 427.
91. Sleipness E.P., Sorg B.A., and Jansen H.T. 2007. Diurnal differences in dopamine transporter and tyrosine hydroxylase levels in rat brain: Dependence on the suprachiasmatic nucleus. Brain Res. 1129: 34.
92. Souetre E., Salvati E., Belugou J.L., Pringuey D., Candito M., Krebs B., Ardisson J.L., and Darcourt G. 1989. Circadian rhythms in depression and recovery: Evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res. 28: 263.
93. Sprouse J., Braselton J., and Reynolds L. 2006. Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing. Biol. Psychiatry 60: 896.
94. Srinivasan V., Smits M., Spence W., Lowe A.D., Kayumov L., Pandi-Perumal S.R., Parry B., and Cardinali D.P. 2006. Melatonin in mood disorders. World J. Biol. Psychiatry 7: 138.
95. Tataroglu O., Aksoy A., Yilmaz A., and Canbeyli R. 2004. Effect of lesioning the suprachiasmatic nuclei on behavioral despair in rats. Brain Res. 1001: 118.
96. Terman M. and Terman J.S. 2005. Light therapy for seasonal and nonseasonal depression: Efficacy, protocol, safety, and side effects. CNS Spectr. 10: 647.
97. Thase, M. E. 2005. Bipolar depression: Issues in diagnosis and treatment. Harv. Rev. Psychiatry 13: 257.
98. Tuma J., Strubbe J.H., Mocaer E., and Koolhaas J.M. 2005. Anxiolytic-like action of the antidepressant agomelatine (S 20098) after a social defeat requires the integrity of the SCN. Eur. Neuropsychopharmacol. 15: 545.
99. Turek F.W., Joshu C., Kohsaka A., Lin E., Ivanova G., McDearmon E., Laposky A., Losee-Olson S., Easton A., Jensen D.R., Eckel R.H., Takahashi J.S., and Bass J. 2005. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308: 1043.
100. Uz T., Ahmed R., Akhisaroglu M., Kurtuncu M., Imbesi M., Dirim Arslan A., and Manev H. 2005. Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum. Neuroscience 134: 1309.
101. Vitaterna M.H., King D.P., Chang A.M., Kornhauser J.M., Lowrey P.L., McDonald J.D., Dove W.F., Pinto L.H., Turek F.W., and Takahashi J.S. 1994. Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science 264: 719.
102. Weber M., Lauterburg T., Tobler I., and Burgunder J.M. 2004. Circadian patterns of neurotransmitter related gene expression in motor regions of the rat brain. Neurosci. Lett. 358: 17.
103. Weiner N., Clement H.W., Gemsa D., and Wesemann W. 1992. Circadian and seasonal rhythms of 5-HT receptor subtypes, membrane anisotropy and 5-HT release in hippocampus and cortex of the rat. Neurochem. Int. 21: 7.
104. Welsh D.K. and Moore-Ede M.C. 1990. Lithium lengthens circadian period in a diurnal primate, Saimiri sciureus. Biol. Psychiatry 28: 117.
105. Wesemann W. and Weiner N. 1990. Circadian rhythm of serotonin binding in rat brain. Prog. Neurobiol. 35: 405.
106. Wirz-Justice A. and Van den Hoofdakker R.H. 1999. Sleep deprivation in depression: What do we know, where do we go? Biol. Psychiatry 46: 445.
107. Wirz-Justice A., Benedetti F., Berger M., Lam R.W., Martiny K., Terman M., and Wu J.C. 2005. Chronotherapeutics (light and wake therapy) in affective disorders. Psychol. Med. 35: 939.
108. Witte K. and Lemmer B. 1991. Rhythms in second messenger mechanisms. Pharmacol. Ther. 51: 231.
109. Xu Y., Padiath Q.S., Shapiro R.E., Jones C.R., Wu S.C., Saigoh N., Saigoh K., Ptacek L.J., and Fu Y.H. 2005. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 434: 640.
110. Yin L., Wang J., Klein P.S., and Lazar M. A. 2006. Nuclear receptor Rev-erbα is a critical lithium-sensitive component of the circadian clock. Science 311: 1002.
111. Zupancic M. and Guilleminault C. 2006. Agomelatine: A preliminary review of a new antidepressant. CNS Drugs 20: 981.